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Abstract The preference of the 'prohormone thiol protease' 
(PTP), n eendkhtte prohormone processing enzyme, for different 
peptlde precursors was assessed In vitro with recombinant 
prohormones near estimated In vlvo levels. Pro-neurapeptide Y 
(pm-NPY), lmmpiome!e .~n (POMC), and proeakephnlin 
(PE) were expressed at Idah levels in £. cot/. Puflfleation of 
Wehoemonm utilized n combIMtion of DEAE-Sepharase, Mono 
Q, and preparative lectrepheresiL lri'P cleaved PE most 
readily, and also cleaved pro.NPY, The proeeming of POMC 
by PTP was minimal. These results demonstrate PTP's 
l~fm~ for cm~ prohermone substrates. 
Key words: Recombinant prohormone; Proprotein 
processing; Cysteine protease 
I. Introduction 
Peptide hormones and neurotransmitters a e synthesized as 
protein precursors that require proteolytic processing at pairs 
of basic amino acid residues to generate active neuropeptides 
[I-3], In biochemical [4-7l and cell biological [8] studies of 
procnkephaUn procemng in adrenal medulla, the primary en- 
kephalin precursor cleaving activity is represented by a novel 
cysteine pretense termed 'prohormone thiol protease' (PTP), 
The roi~ of PTP in enkephalin production in chromaffln cells 
was clearly demonstrated by complete blockade of cAMP- 
stimulated enkephalin levels by a potent cysteine protease in- 
hibitor of PTP [8], Proenkephalin processing also involves the 
sebtilisin-like PCil3 and PC2 proteases (PC=prohormone 
convertase) [9], and a 70 kDa aspartic proteinase [10]. 
The neumendocrine,specific prohormone convertases (PC) 
PCll3 and PC2 [I-3], that were cloned based on active site 
homology to the yeast Kex2 gene required in pro~-mating 
factor proces~ng [11], have been demonstrated to process 
proinsulin, POMC, and many other prohormones. Character- 
ization of recombinant PCII3 and PC2 through several ap- 
proaches-(a) o~,xpression of PC enzymes with POMC, and 
other prohormone cDNAs, in cell lines [1-3,12,13], (b) char- 
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acterization of purified recombinant PC enzymes [1-3,14-16], 
and (c) characterization f purified native PC enzymes from 
endogenous tissue sources [9,17,18]-demonstrate that these 
proteases possess appropriate cleavage specificity, pH opti- 
mum, and kinetic properties for prohormone processing. Evi- 
dence also indicates participation of a 70 kDa aspartic pro- 
teinase in proenkephalin processing in adrenal medulla [10], 
and in POMC processing in pituitary by a protease known as 
'POMC converting enzyme' (PCE) [19]. Overall, these studies 
indicate that proteases of different mechanistic classes are in- 
volved in prohormone processing. 
The different primary sequences of prohormones lead to the 
prediction that processing proteases may recognize and cleave 
one prohormone more readily than another. This hypothesis 
was addressed in this study by comparing the ability of the 
prohormone thiol protease (PTP) to process recombinant pro. 
neuropeptide Y, proopiomelanocortin, and proenkephalin. 
Pro-neuropeptide Y, proopiomelanocortin, and proenkepha- 
lin, as well as their peptide products, are co-localized with 
PTP in adrenal medulla and pituitary ([4,20,21]; Hook et 
al., manuscript in preparation). High level expression of these 
prohormones in E. coli has made it possible to achieve in vitro 
prohormone concentrations ear estimated in vivo levels. Re. 
suits demonstrate that PTP clearly possesses preference for 
certain prohormone substrates. 
2. Experimental 
2. !. Prohormone expression constructs 
The cDNAs for rat pro-neuropeptide Y (pro-NPY) [22], porcine 
proo#omelanocortm (POMC) [23], and rat proenkephalin [7] were 
subcloned into the pET3c expression vector [24] (Fig. I A). Pro- 
NPY and POMC cDNAs were amplified by PCR, with deletion of 
the signal sequences and incorporation fNdel and BamHl restriction 
sites for subeloning into the pET3c vector [24]. Primers for PCR of 
pro-NPY were 5'-AAACATATGTACCCCTCCAAGCCG.Y and 5'- 
AAAGGATCCCCATCACCACATGGAAG-Y; primers for PCR of 
POMC were 5'-AAACATATGTGGTGCTTGGAGAGCAGCCAG. 
TGTCAG-Y and 5'-AAAGGATCCCCCTCACTGGCCCTTCTTG - 
TGGGCGTTCTT-3 °. PCR reactions (according to the protocol of 
the Perkin-Elmer PCR kit) contained kit ! ng eDNA as template, 
and primers at 0.2 or 0.1 pM, with thermocycling consisting of 30 
cycles of I min each at 94, 50, and 720C. The PCR reaction for 
POMC also included 10% glycerol. The amplified pro-NPY (227 
bp) and POMC (748 bp) DNAs were digested with NdeI and BamHI, 
lignted with T4 ligase to the pET3c plasmid vector digested with Ndel 
and BamHl, and transformed into DH5a E. coil cells. Pro-NPY/ 
pET3c and POMC/pET3cplasmid constructs were subjected to 
DNA sequencing, aspreviously described [25], to confirm that PCR 
reactions generated authentic pro-NPY and POMC nucleotide 
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Fig. 1. Expression vector pET3c and illustration of prohormone structures for Ero-NPY, POMC, and proenkephalin. (A) Expression with the 
pET3c T7 expression vector. Prohormone cDNAs were subcloned at Ndel and BamHI restriction sites of the pET3c vector. (B) Prohormone 
structures. Pro-NPY contains NPY and COOH-terminal peptide (CTP) sequences separated by a Lys-Arg pair. Proopiomelanocortin (POMC) 
contains the peptides ACTH, 13-endorphin, ~-MSH, joining peptide (JP). Proenkephalin contains 4 copies of (Met)enkephalin (M) (YGGFM), 
one copy of (Leu)enkephalin (L) (YGGFL), and the enkephalin-related peptides known as the octapeptide (O) (YGGFMRGL) and heptapep- 
tide (H) (YGGFMRF). 
sequences. The proenkephalin (PE) expression construct, PE/pET3c, 
was prepared as described previously [7]. 
2.2. Recombinant prohormone xpression and purification 
Recombinant pro-NPY, POMC, and proenkephalin were expressed 
by IPTG (isopropyl.~-thiogalactopyranoside) induction of 
BL21(DE3) E. coli cells containing the prohormone/pET3c constructs, 
with expression conducted as described previously [7]. Expression was 
assessed by Western blots utilizing anti-NPY serum (! :200 final dilu- 
tion, from Accurate Chemicals, New York) to detect pro-NPY, and 
anti-p-LPH serum (1:1000 final dilution, from the National Hormone 
and Pituitary Program, Gaithersburg, MD) to detect POMC. Expres- 
sion of recombinant proenkephalin i  E. coli has been confirmed by 
Western blots with anti-PE monoclonal ntibody [7]. For large-scale 
expression and purification, pro-NPY and POMC were expressed as 
10 and 5 I cell cultures, respectively; proenkephalin was expressed 
from 5 ! of culture. 
For purification of pro-NPY, cells were tr.elleted (2600 X g for 20 
min), resuspended in 55 ml of 50 mM Tris-l-!Cl, pH 7.5 (buffer A), 
and lysed by sonication. After centrifugation ,>f the lysate (27 000 x g 
for 30 min at 4°C), the supernatant was chromatographed on a 
DEAE-Sepharose ion exchange column (1.5x40 cm) equilibrated in
buffer A, with elution of pro-NPY by a 0-500 mM NaCi gradient 
(500 ml gradient) in buffer A (25 ml/h flow rate). Pro-NPY in column 
fractions (4.5 mllfraction) was monitored by anti-NPY Western blots 
and Coom~ssie blue staining of SDS-PAGE gels. Pro-NPY fractions 
were pooled, concentrated by the Speed-Vac, and chromatographed 
two times on a molecular sieving Superose-12 FPLC column equili- 
brated in buffer A. Purified pro-NPY was subjected to peptide micro- 
sequencing and amino acid composition analyses that confirmed the 
purified prohormone as pro-NPY. 
For purific~Kion of POMC, cells from 5 1 of culture were pelleted 
(2600 × g for 20 rain), resus~ended in 20 ml of 50 mM Tris-HCl, pH 
7.5, pelleted again by centrifugation, and resuspendcd in20 ml 50 mM 
MOPS-HCI, pH 6.5, 6.0 M urea (buffer B). Cells were lysed by soni- 
cation, and solubilized POMC was obtained as the supernatant result- 
ing from centrifugation at 27 000 × g for 30 rain. The supernatant was 
applied to DEAE column (!.5×36 cm) equilibrated with buffer B 
(flow rate of 16 mi/h), and POMC was eluted with a 0-500 mM 
NaC! gradient (400 ml gradient) in buffer B. Fractions (3.7 ml) 
were assayed for POMC by anti-I}-LPH Western blots. POMC posi- 
tive fractions were pooled and dialyzed against 50 mM Tris-HCl, pH 
7.0, and concentrated to 200-500 I~! by the Speed-Vac. POMC was 
then subjected to preparative SDS-PAGE gel electrophoresis using the 
Biorad model 491 preparative c ll, performed as previously described 
[7]. Purified POMC obtained from this step was dialyzed against 0.2 
mM Tris-HCI pH 7.5, lyophilized, and resuspended in 250 Ixl H20. It 
is noted that any residual SDS has no effect on PTP enzyme activity, 
since proenkephalin, whose purification i cludes the SDS-PAGE step, 
was appropriately cleaved by PTP at paired basic residues to generate 
products known to be present in vivo [7]. 
2.3. Prohormone thiol protease (PTP) incubation with prohormones 
The prohormone thiol protease (PTP) was purified from bovine 
chromaffin granules of adrenal medulla as previously described [4], 
Pro-NPY (4 pg, equivalent to 6 ttM pro-NPY) and PTP (1 ng) 
were incubated in 100 mM citrate-NaOH, pH 5.0, 1 mM EDTA, 
I mM DTT, and 10 mM CHAPS (3.[3.chloramidopropyldimethylam- 
monio]-l-propanesulfonate) in a total volume of 80 [.tl for 10 rain to 
8 h at 37°C. Enzyme reactions were subjected to 15% polyacrylamide 
Tricine-buffered SDS-PAGE gels by the method of Schaegger and 
Von Jagow [26], transblotted to PVDF membranes, and stained 
with amido black. POMC (4 ~tg) and PTP (1 ng) were incubated for 
6 h at 37°C; POMC reactions were analyzed by western blots with 
anti-[bLPH serum. PE and PTP were incubated for 1-24 h at 37°C, 
and PE reactions were analyzed by SDS-PAGE gel.,' blotted to PVDF 
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Fig. 2. Expression of pro-NPY and POMC, and purified recombinant prohormones. (a) Pro.NPY expression. (i) Pro-NPY expression detected 
on SDS-PAGE gels. Expression of pro-NPY is indicated by IPTG induction (2 h incubation of cells with IPTG) of an 8 kDa band detected by 
Coomassie blue staining of a SDS-PAGE gel. (ii) Pro-NPY expression detected by Western blot. Anti-NPY immunoblots indicated IPTG in- 
duction of the pro-NPY immunoreactive 8 kDa band. (b) POMC expression. Expression of POMC was induced when cells were incubated 
with lPTG for 0,5, !, or 2 h. Anti-l$-LPH immunoblots demonstrate expression of intact 35 kDa POMC, (c) Purified pro-NPY. Pro-NPY (5 
pg) was purified to apparent homogeneity, as illustrated by the single band of 8 kDa pm-NPY. (d) Purified POMC. POMC (2 pg) was purified 
to apparent homogeneity, as illustrated by the single band of 35 kDa POMC. 
membranes and stained with ainido black. Densitometry of gels (per- 
formed as previously described [7]} was used to quantitate he amount 
of pmhormones cleaved, 
3. Results and dbeumlun 
3. i, £vpression and pur~ication of recombinant pro.NP Y and 
POMC 
The T7 expression system utilizing the pET3c expression 
vector (Fig, IA) generates high levels of recombinant prohor- 
mones, Expression of pro,NPY, POMC, and proenkephalin 
(PE) prohormones (Fig, I B) was successfully achieved in this 
study with the pET3c vector, Expression and purification of 
recombinant pro-NPY and POMC is described in this report; 
expression and purification of proenkephalin has been de- 
scribed [7], 
Induction by lPTG of pro-NPY expression in E, coli was 
apparent after 2 h incubation at 37°C (Fig, 2a), The expres- 
sion of pro-NPY as a 8 kDa band was detected on SDS- 
PAGE gels (Fig, 2ai); western blot with anti-NPY (Fig. 
2ad) indicated this 8 kDa band to be immunoreactive for 
NPY, Also, the observed apparent Mr of 8 kDa is consistent 
with the theoretical si~ of 8059 Mr of pro-NPY, based on the 
deduced primary sequence, from the pro-NPY eDNA [22]. 
POMC expression was detected by western blots with anti- 
~-LPH serum (Fig, 2b) which recognizes the COOH-terminai 
segment of POMC that includes [$-endorphin [23]. Intact 
POMC of 35 kDa is consistent with the theoretical Mr of 
POMC [23]. The time-dependent appearance of two lower 
molecular weight bands of POMC immunoreactivity ndicated 
some degradation of POMC within the cells. In addition, it 
was noted that lower levels of POMC were expressed com- 
pared to pro-NPY, since POMC could only be detected by 
western blots, and not by Coomassie blue staining of proteins 
on SDS-PAGE gels. 
Pro-NPY was purified by chromatography of solubilized 
pro-NPY by DEAE-Sepharose and Superose-12 FPLC col.. 
umns. The DEAE-Sepharose step provided a 20-fold purifica- 
tion of pro-NPY with a 30% yield. The Superose-12 FPLC 
step resulted in purified pro-NPY, as indicated by a single 8 
kDa pro-NPY band on SDS-PAGE (Fig. 2c). Pro-NPY was 
purified with a yield of 20% and a 170-fold purification. 
Table ! 
Rates of PTP cleav'~ge of proenkephalin, pro-NPY, and POMC 
Prohormone Rate of processing (pmollmin 
per mg) 
Proenkephalin 3.13  
Pm-NPY 1.75 
POMC 4.7 x 10 -3 
The rates of PTP cleavage of proenkephalin, pro-NPY, and POMC 
were calculated. Prohormones (at micromolar concentrations, see 
section 2) were incubated in vitro with PTP under optimum, stand- 
ard PTP assay conditions [4,7]. 
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Fig. 3. PTP processing of pro-NPY, POMC, and PE. (a) Pro-NPY. (i) SDS-PAGE of pro-NPY incubated with PTP in a time course study. 
Pro-NPY (4 I~g) was incubated with PTP (1 ng) for 0-8 h. Reaction samples were subjected to SDS-PAGE, electrophoretically b otted to 
PVDF membranes, and stained with amido black. The arrow indicates a product of 4 kDa. (ii) Time course of pro-NPY processing. Densito- 
merry of pro-NPY on SDS-PAGE gels (from panel (ai)) quantitated the degree of pro-NPY processing by PTP. (b) POMC. POMC (4 I~g) was 
incubated without (lane 1) and with purified PTP (1 rig) (lane 2), and anti-13-LPH western blottifig was utilized to assess the degree of POMC 
remaining after incubation with PTP. (c) Proenkephalin. (i) Proenkephalin a d PTP, SDS-PAGE gels. Proenkephalin (8 I~g) was incubated with 
PTP (I rig) for 0, !, 6, and 24 h (lanes !-4, respectively) at 37°C. Reactions were subjected to SDS-PAGE, electrophoretically transferred to
PVDF membranes, and stained with amido black. (ii) Percent proenkephalin cleaved. Densitometry assessed the relative amounts of proenke- 
phalin cleaved. 
POMC was purified by DEAE-Sepharose and preparative 
SDS-PAGE gel electrophoresis. The DEAE-Sepharose col- 
umn provided a 60% recovery and a 30-fold purification. Sub- 
sequent preparative gel electrophoresis isolated the intact 35 
kDa POMC. Purification of POMC to apparent homogeneity 
~as indicated hy the single band of 35 kDa POMC on SDS- 
PAGE (Fig. 2d). 
3.2 P,.t,hormone thiol protease preference for prohormone 
substrates 
The ability of the prohormone thiol protease (PTP) to 
cleave pro-NPY, POMC, and proenkephalin (PE) was as- 
sessed under identical PTP reaction conditions, with in vitro 
prohormones at micromolar concentrations that represent in 
vivo prohormone l vels [27]. Pro-NPY was readily cleaved by 
PTP, as demonstrated in a time course study showing cleavage 
of 50% of pro-NPY within 2.5 h (Fig. 3a). PTP generated a 4 
kDa product that is consistent with the production of NPY 
since the NHz-terminus (YPSKXDNXGE, determined by 
peptide microsequencing) of the 4 kDa band corresponds to 
NPY, and its apparent Mr is consistent with NPY. These 
results are compatible with PTP cleavage at a Lys-Arg paired 
basic residue site [4-7] that would result in NPY. 
In contrast o pro-NPY, POMC was cleaved more slowly 
by PTP (Fig 3b). Even after 24 h incubation of POMC with 
PTP, only 2-3% of the POMC was cleaved. Pro-NPY, on the 
other hand, was completely cleaved by 6 h incubation (Fig. 
3a). In addition, PTP did not cleave [3-1ipotropin hormone 
(I3-LPH), the COOH-terminal segment of POMC that con- 
tains lS-endorphin flanked by a paired basic residue cleavage 
site (data not shown). These results uggest hat POMC and 
its intermediates may be poor substrates for PTP. 
Comparison of proenkephalin (PE) with pro-NPY and 
POMC processing by PTP indicated that PTP prefers proen- 
kephalin among the prohormones tested. PE was readily 
cleaved by PTP, as shown by cleavage of the majority of 
PE within 1 h (Fig. 3c). Comparison of the extent of prohor- 
mones cleaved after 1 h incubation showed ti~at 80% of PE 
was processed, 20% of pro-NPY was processed, and almost 
no POMC was processed (Fig. 4). The observed rates of ~ro- 
hormone cleavage (Table 1) indicate that proenkephalin was 
cleaved at a rate that was nearly 2-fold greater than that for 
pro-NPY. However, both proenkephalin and pro-NPY were 
cleaved at approximately 1000 times (3 orders of magnitude) 
greater rates than that observed for POMC. These results 
suggest proenkephalin or pro-NPY as preferred PTP prohor 
mone substrates. 
3.3. Conclusions 
Results from this study demonstrate hat the prohormone 
thiol protease (PTP), a candidate prohormone processing en- 
zyme, shows preference for prohormone substrates. In parti- 
cular, proenkephalin was the most efficiently cleaved precur- 
sor among the prohormones xamined in this study. Pro-NPY 
was also processed quite etiiciently, with processing of pro- 
NPY occurring at approximately half the rate observed for 
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Fig. 4. Relative processing of proenkephalin, pro-NPY, and POMC 
by tWP. Comparison of the extent of processing of prohormones 
(at micromolar concentrations) after 1 h incubation with PTP from 
time coune studies is illustrated. 
proenkephalin. However, PTP processing of POMC was 
slower by 3 orders of magnitude. 
These findings suggest hat elucidation of the primary pro- 
cessing protease(s) involved in processing a particular prohor- 
mone may depend on the selectivity of processing enzymes for 
prohormone substrates. The preference of a processing en- 
zyme for a proprotein substrate may involve selective recogni- 
tion of particular prohormone structures, as defined by the 
unique primary sequence and three-dimensional conformation 
of each prohormone, it i~ clear that ftlrther studies of prohor- 
mone selectivity of processing enzymes will be important in 
the elucidation of the major processing proteases required for 
converting different prohormones into bioactive neuropep- 
tides, 
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